Resonance Health attended the EASL Digital NAFLD Summit 2021 on 16 – 17 September and participated with insights into developments in artificial intelligence-based approaches to NAFLD management using HepaFat-AI.
We are delighted to present the abstract we shared titled “Diagnostic accuracy of liver steatosis using artificial intelligence”.
To read it please click here.